Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDE Inhibitors on Chorioretinal Blood Flow (PhiGS)
NCT04052269Phase 3Suspended
- Sponsor
- Imperial College London
- Start
- Jun 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001, tadalafil in Glaucoma, sponsored by Imperial College London. Started Jun 2019; status: suspended.
02
Drugs
ASP-001tadalafil
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT04052269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04052269.